Accordingly, the present study has been focused on investigating the potential effect of a drug with combined effects such as TELM, an AT1 receptor blocker and a PPARγ activator, either alone or combined with PZQ, on S. mansoni-induced liver fibrosis in mice. The gene discussed is PPARG; the disease is Hepatic fibrosis.